Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy of Biosimilar Candidate ABP 710 in a Phase 3 Study in Subjects with Moderate to Severe RA: Additional Analysis Focusing on the ACR Individual Components Genovese, M., Sanchez-Burson, J., Balazs, E., Everding, A., Oh, M., Fanjiang, G., Cohen, S. WILEY. 2019
View details for Web of Science ID 000507466900520